Cargando…
Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?
Advances in diagnostics of inflammatory bowel diseases (IBD) and improved treatment strategies allowed the establishment of new therapeutic endpoints. Currently, it is desirable not only to cease clinical symptoms, but mainly to achieve endoscopic remission, a macroscopic normalization of the bowel...
Autores principales: | Fabian, Ondrej, Bajer, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521520/ https://www.ncbi.nlm.nih.gov/pubmed/36185628 http://dx.doi.org/10.3748/wjg.v28.i36.5300 |
Ejemplares similares
-
Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
por: Crispino, Federica, et al.
Publicado: (2023) -
Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023) -
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023) -
Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017) -
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget
por: Núñez F, Paulina, et al.
Publicado: (2022)